Coherent Says Revised II-VI Proposal Superior to Lumentum Agreement - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Coherent Says Revised II-VI Proposal Superior to Lumentum Agreement

    Article obtained from Photonics RSS Feed.

    Coherent determined that a revised acquisition proposal from optical components and semiconductor materials manufacturer II-VI is superior to the terms of a January merger agreement between Coherent and laser and optical fiber developer Lumentum.

    Coherent notified Lumentum it intends to terminate that agreement if it does not receive a revised proposal from Lumentum by Thursday, March 11.

    The revised proposal from II-VI builds on a previous unsolicited acquisition proposal that II-VI submitted to Coherent on Feb. 12 following an unsolicited bid from MKS Instruments. Per terms of the new proposal, each share of Coherent common stock would be exchanged for $170 in cash and 1.0981 shares of II-VI common stock following completion…

    READ MORE
    Mar, 08 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.